Provided by Tiger Trade Technology Pte. Ltd.

Protagonist Therapeutics

82.76
-0.3300-0.40%
Post-market: 82.760.00000.00%18:13 EST
Volume:577.97K
Turnover:47.80M
Market Cap:5.17B
PE:125.39
High:83.69
Open:83.26
Low:80.72
Close:83.09
52wk High:96.54
52wk Low:33.70
Shares:62.52M
Float Shares:43.15M
Volume Ratio:1.49
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6600
EPS(LYR):4.23
ROE:7.80%
ROA:1.82%
PB:8.02
PE(LYR):19.57

Loading ...

Feb 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 27, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 27, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Oct 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jul 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Major Issues Report

Form 8-K - Current report